Cadham, C. J., Reicher, J., Muelly, M., & Hutton, D. W. (2025). Cost-effectiveness of novel diagnostic tools for idiopathic pulmonary fibrosis in the United States. BMC Health Services Research, 25(1). https://doi.org/10.1186/s12913-025-12506-1

CADHAM, Christopher J., REICHER, Joshua, MUELLY, Michael und HUTTON, David W., 2025. Cost-effectiveness of novel diagnostic tools for idiopathic pulmonary fibrosis in the United States. BMC Health Services Research. 1 Dezember 2025. Vol. 25, no. 1, . DOI 10.1186/s12913-025-12506-1.

Cadham, C. J., J. Reicher, M. Muelly, und D. W. Hutton. „Cost-Effectiveness of Novel Diagnostic Tools for Idiopathic Pulmonary Fibrosis in the United States“. BMC Health Services Research, Bd. 25, Nr. 1, Dezember 2025, https://doi.org/10.1186/s12913-025-12506-1.

Cadham, Christopher J./Reicher, Joshua/Muelly, Michael/Hutton, David W.: Cost-effectiveness of novel diagnostic tools for idiopathic pulmonary fibrosis in the United States, BMC Health Services Research 2025,

Cadham, C.J., Reicher, J., Muelly, M. und Hutton, D.W. (2025), „Cost-effectiveness of novel diagnostic tools for idiopathic pulmonary fibrosis in the United States“, BMC Health Services Research, Vol. 25 No. 1, verfügbar unter:https://doi.org/10.1186/s12913-025-12506-1.